| abstract |
Leukotriene-B4 derivates are disclosed having the formula (I), in which R1 is the residue CH2OH, the residue COOR5 or the residue CONHR6, A is a transmethylene group, a trans-CH=CH-CH=CH-methylene group or a tetramethylene group, B is a straight or branched chain, saturated or insaturated alkylene group with up to 10 C-atoms, D is a direct link, oxygen, sulfur, a -C=C- group or a -CH=CR7- group, B and D form together a direct link, R2 and R3 can be identical or different, and represent a hydrogen atom or an acid residue of an organic acid with 1 to 15 C-atoms and R4 is a hydrogen atom, an alkyl residue, a cycloalkyl residue, an aryl residue or a heterocyclic residue with 5 to 6 members and, when R5 is a hydrogen atom, their salts with physiologically compatible bases and their cyclodextrinclathrates. A process for producing these derivates and their use as medicaments are also disclosed. |